Jnpc Pharma Innovation Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Jnpc Pharma Innovation
Jnpc Pharma Innovation Limited (JPIL) is a Public Limited Indian Non-Government Company incorporated in India on 23 November 2011 and has a history of 13 years and three months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Yancharla Nagaraja, Popuri Krishna, and Pakanati Reddy serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100TG2011PLC077628
- Company No.
077628
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2011
- Date of AGM
07 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Jnpc Pharma Innovation?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yancharla Nagaraja  | Director | 03-Jul-2021 | Current |
| Popuri Krishna | Director | 21-Jan-2013 | Current |
| Pakanati Reddy | Director | 05-Feb-2024 | Current |
Financial Performance of Jnpc Pharma Innovation.
Jnpc Pharma Innovation Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jnpc Pharma Innovation?
In 2017, Jnpc Pharma Innovation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Visakha Pharmacity LimitedPopuri Krishna is a mutual person
Mdda-Ramky Isbus Terminal LimitedYancharla Nagaraja is a mutual person
- Ramky Elsamex Hyderabad Ring Road Limited
Yancharla Nagaraja is a mutual person
- Ramky Multi Product Industrial Park Limited
Yancharla Nagaraja is a mutual person
- Ramky - Midc Agro Processing Park Limited
Pakanati Reddy is a mutual person
Ramky Infrastructure LimitedYancharla Nagaraja is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jnpc Pharma Innovation?
Unlock and access historical data on people associated with Jnpc Pharma Innovation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jnpc Pharma Innovation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jnpc Pharma Innovation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
